State-Level Disparity in Lung Cancer Survival in the United States
Rationale: The cancer mortality-to-incidence ratio (MIR) can serve as a population-based indicator for cancer care outcomes. In the US, evaluation of lung cancer survival by individual states has not been evaluated.Objective: To assess the association between lung cancer survival by using MIRs and s...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.01449/full |
id |
doaj-d94f176c36724e04bae9671b58e88c7e |
---|---|
record_format |
Article |
spelling |
doaj-d94f176c36724e04bae9671b58e88c7e2020-11-25T03:39:12ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-08-011010.3389/fonc.2020.01449566849State-Level Disparity in Lung Cancer Survival in the United StatesYu-Che Lee0Yu-Che Lee1Yu-Che Lee2Rafael A. Calderon-Candelario3Rafael A. Calderon-Candelario4Gregory E. Holt5Gregory E. Holt6Michael A. Campos7Michael A. Campos8Mehdi Mirsaeidi9Mehdi Mirsaeidi10Mehdi Mirsaeidi11Division of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, United StatesDivision of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDivision of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDivision of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDivision of Pulmonary and Critical Care Medicine, University of Miami Miller School of Medicine, Miami, FL, United StatesSection of Pulmonary Medicine, Miami Veterans Affairs Healthcare System, Miami, FL, United StatesDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, United StatesRationale: The cancer mortality-to-incidence ratio (MIR) can serve as a population-based indicator for cancer care outcomes. In the US, evaluation of lung cancer survival by individual states has not been evaluated.Objective: To assess the association between lung cancer survival by using MIRs and state-level health disparities in the United States.Methods: We calculated 5-year lung cancer MIR averages from 2011 to 2015 using the United States Cancer Statistics (USCS) data. America's Health Rankings (AHR) is a platform using weighted measures in five different categories to calculate annual state health rankings. Five-year averages from 2011 to 2015 of the health uninsured rate and 4-year averages from 2011 to 2014 of health spending per capita were obtained from the U.S. Census Bureau and Centers for Medicare & Medicaid Services. Linear regression analyses were performed to determine the associations between cancer survival value (CSV) = (1 – MIR) × 100% and state health variables.Results: During the study period, the 5-year averages of age-adjusted incidence, mortality rates, and CSVs were 60.3 ± 2.1 per 100,000 population, 43.4 ± 2.1 per 100,000, and 27.9 ± 3.9%, respectively. Among the 50 states, Connecticut had the highest CSV (38.6 ± 1.7%) whereas Nevada had the lowest CSV (18.7 ± 6.5%). Hawaii had the highest health ranking and Mississippi had the lowest ranking in 2016. States with better health rankings, lower health uninsured rates, and higher health spending were significantly associated with higher CSVs (R2 = 0.418, P < 0.001; R2 = 0.352, P < 0.001; R2 = 0.142, P = 0.007, respectively).Conclusions: There are significant differences in lung cancer survival within the United States. Lung cancer survival by using CSV was strongly associated with state health disparities, and it can be an applicable measure to evaluate the state-level health disparities in the United States.https://www.frontiersin.org/article/10.3389/fonc.2020.01449/fulllung cancer survivalAmerica's Health Rankingshealth economy (source: MeSH NLM)insurancedisparity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yu-Che Lee Yu-Che Lee Yu-Che Lee Rafael A. Calderon-Candelario Rafael A. Calderon-Candelario Gregory E. Holt Gregory E. Holt Michael A. Campos Michael A. Campos Mehdi Mirsaeidi Mehdi Mirsaeidi Mehdi Mirsaeidi |
spellingShingle |
Yu-Che Lee Yu-Che Lee Yu-Che Lee Rafael A. Calderon-Candelario Rafael A. Calderon-Candelario Gregory E. Holt Gregory E. Holt Michael A. Campos Michael A. Campos Mehdi Mirsaeidi Mehdi Mirsaeidi Mehdi Mirsaeidi State-Level Disparity in Lung Cancer Survival in the United States Frontiers in Oncology lung cancer survival America's Health Rankings health economy (source: MeSH NLM) insurance disparity |
author_facet |
Yu-Che Lee Yu-Che Lee Yu-Che Lee Rafael A. Calderon-Candelario Rafael A. Calderon-Candelario Gregory E. Holt Gregory E. Holt Michael A. Campos Michael A. Campos Mehdi Mirsaeidi Mehdi Mirsaeidi Mehdi Mirsaeidi |
author_sort |
Yu-Che Lee |
title |
State-Level Disparity in Lung Cancer Survival in the United States |
title_short |
State-Level Disparity in Lung Cancer Survival in the United States |
title_full |
State-Level Disparity in Lung Cancer Survival in the United States |
title_fullStr |
State-Level Disparity in Lung Cancer Survival in the United States |
title_full_unstemmed |
State-Level Disparity in Lung Cancer Survival in the United States |
title_sort |
state-level disparity in lung cancer survival in the united states |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2020-08-01 |
description |
Rationale: The cancer mortality-to-incidence ratio (MIR) can serve as a population-based indicator for cancer care outcomes. In the US, evaluation of lung cancer survival by individual states has not been evaluated.Objective: To assess the association between lung cancer survival by using MIRs and state-level health disparities in the United States.Methods: We calculated 5-year lung cancer MIR averages from 2011 to 2015 using the United States Cancer Statistics (USCS) data. America's Health Rankings (AHR) is a platform using weighted measures in five different categories to calculate annual state health rankings. Five-year averages from 2011 to 2015 of the health uninsured rate and 4-year averages from 2011 to 2014 of health spending per capita were obtained from the U.S. Census Bureau and Centers for Medicare & Medicaid Services. Linear regression analyses were performed to determine the associations between cancer survival value (CSV) = (1 – MIR) × 100% and state health variables.Results: During the study period, the 5-year averages of age-adjusted incidence, mortality rates, and CSVs were 60.3 ± 2.1 per 100,000 population, 43.4 ± 2.1 per 100,000, and 27.9 ± 3.9%, respectively. Among the 50 states, Connecticut had the highest CSV (38.6 ± 1.7%) whereas Nevada had the lowest CSV (18.7 ± 6.5%). Hawaii had the highest health ranking and Mississippi had the lowest ranking in 2016. States with better health rankings, lower health uninsured rates, and higher health spending were significantly associated with higher CSVs (R2 = 0.418, P < 0.001; R2 = 0.352, P < 0.001; R2 = 0.142, P = 0.007, respectively).Conclusions: There are significant differences in lung cancer survival within the United States. Lung cancer survival by using CSV was strongly associated with state health disparities, and it can be an applicable measure to evaluate the state-level health disparities in the United States. |
topic |
lung cancer survival America's Health Rankings health economy (source: MeSH NLM) insurance disparity |
url |
https://www.frontiersin.org/article/10.3389/fonc.2020.01449/full |
work_keys_str_mv |
AT yuchelee stateleveldisparityinlungcancersurvivalintheunitedstates AT yuchelee stateleveldisparityinlungcancersurvivalintheunitedstates AT yuchelee stateleveldisparityinlungcancersurvivalintheunitedstates AT rafaelacalderoncandelario stateleveldisparityinlungcancersurvivalintheunitedstates AT rafaelacalderoncandelario stateleveldisparityinlungcancersurvivalintheunitedstates AT gregoryeholt stateleveldisparityinlungcancersurvivalintheunitedstates AT gregoryeholt stateleveldisparityinlungcancersurvivalintheunitedstates AT michaelacampos stateleveldisparityinlungcancersurvivalintheunitedstates AT michaelacampos stateleveldisparityinlungcancersurvivalintheunitedstates AT mehdimirsaeidi stateleveldisparityinlungcancersurvivalintheunitedstates AT mehdimirsaeidi stateleveldisparityinlungcancersurvivalintheunitedstates AT mehdimirsaeidi stateleveldisparityinlungcancersurvivalintheunitedstates |
_version_ |
1724540321139785728 |